Nuveen’s Intersect ENT, Inc XENT Stock Holding History

Nuveen’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-352,370	Closed	-$9.78M	–	3620
2022 Q1	$9.78M	Sell	352,370 -5,994	-2%	-$164K	﹤0.01%	1653
2021 Q4	$9.79M	Sell	358,364 -11,078	-3%	-$300K	﹤0.01%	1710
2021 Q3	$10M	Sell	369,442 -255,433	-41%	-$6.32M	﹤0.01%	1779
2021 Q2	$10.7M	Sell	624,875 -37,077	-6%	-$694K	﹤0.01%	1830
2021 Q1	$13.8M	Sell	661,952 -29,751	-4%	-$687K	﹤0.01%	1593
2020 Q4	$15.8M	Buy	691,703 +89,129	+15%	+$1.7M	0.01%	1398
2020 Q3	$9.83M	Buy	602,574 +30,512	+5%	+$553K	﹤0.01%	1537
2020 Q2	$7.75M	Sell	572,062 -12,289	-2%	-$143K	﹤0.01%	1660
2020 Q1	$6.92M	Sell	584,351 -74,859	-11%	-$1.66M	﹤0.01%	1524
2019 Q4	$16.4M	Buy	659,210 +81,381	+14%	+$1.65M	0.01%	1288
2019 Q3	$9.83M	Buy	577,829 +16,212	+3%	+$295K	﹤0.01%	1583
2019 Q2	$12.8M	Buy	+561,617	New	+$15.1M	0.01%	1446
2018 Q3	–	Sell	-67,770	Closed	-$2.54M	–	1108
2018 Q2	$2.54M	Buy	67,770 +31,877	+89%	+$1.25M	0.02%	591
2018 Q1	$1.41M	Buy	35,893 +5,203	+17%	+$190K	0.01%	673
2017 Q4	$994K	Buy	+30,690	New	+$920K	0.01%	744

Nuveen's XENT Position: Q2 2022 in Review

Nuveen sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 352,370 shares — an estimated $9.78M sold.

Nuveen first reported a position in XENT in Q4 2017 and held it in 15 quarters. The position peaked at $16.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Nuveen reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Nuveen sold 352,370 Intersect ENT, Inc shares in Q2 2022, an estimated $9.78M.
Nuveen first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 15 quarters.
Nuveen's Intersect ENT, Inc position peaked at $16.4M in Q4 2019.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.